Product Images Methylphenidate Hydrochloride
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Methylphenidate Hydrochloride NDC 42291-571 by Avkare, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Label 1 - Label 4229156890
This appears to be a partial label of a prescription medication for Methylphenidate Hydrochloride, likely in extended-release tablet form. The dosage information is not entirely clear, but it appears to be 20 milligrams. The brand name is not provided. The remaining text is not clear and may be a manufacturer or supplier name, dosage instructions, or other information.*
Label 2 - Label 4229156990
This is a description of a medication called Methylphenidate HCI in extended-release tablet form. The recommended storage temperature is between 20°C (68°F) and 25°C (77°F), and it should be protected from humidity. The medication has a National Drug Code (NDC) of 42291-569-90. The remaining text does not provide any additional useful information.*
Label 3 - Label 4229157090
This is a label for AVKARE Methylphenidate HCI extended-release tablets, a prescription drug used to treat ADHD. It contains 90 tablets in one bottle and the recommended dosage is stated. The medication should be stored in controlled room temperature and protected from humidity. The manufacturer is MOTE and the transaction is made by Ao Pk I NV UC.*
Label 4 - Label 4229157190
This appears to be a medication label for Methylphenidate HCI extended-release tablets with a strength of 25mg. The label mentions that the medication should be stored at room temperature and protected from light. The recommended dosage is not clear.*
Structural Formula - methylphenidate hcl extended release tablets usp 1
figure 1 - methylphenidate hcl extended release tablets usp 2
This is a chart showing the concentration (in ng/mL) of Mezn Plasma Methylphenidate under two different dosages: the extended-release 18 mg taken once daily and 5 mg taken three times daily. The chart displays measurements taken at various times, ranging from 4 to 32.*
Figure 2 - methylphenidate hcl extended release tablets usp 3
The text provides information about the medication "Maximum 15 - Methylphenidate HCI", which is available in extended-release tablets and is taken once a day. The text also includes a chart with symptom scores for three different studies, with "No Symptoms" being a score of 0 and a higher score indicating more symptoms. The readability of the chart is limited due to errors, but the general information is discernible.*
Figure 3 - methylphenidate hcl extended release tablets usp 4
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.